Balyasny Asset Management’s ACELYRIN SLRN Stock Holding History

Balyasny Asset Management’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,305,015	Closed	-$3.22M	–	3304
2025 Q1	$3.22M	Buy	+1,305,015	New	+$3.1M	0.01%	1467
2024 Q4	–	Sell	-43,868	Closed	-$216K	–	3223
2024 Q3	$216K	Buy	43,868 +7,491	+21%	+$38.7K	﹤0.01%	2542
2024 Q2	$160K	Sell	36,377 -16,946	-32%	-$79.4K	﹤0.01%	2369
2024 Q1	$360K	Buy	+53,323	New	+$405K	﹤0.01%	2185
2023 Q3	–	Sell	-233,398	Closed	-$4.88M	–	2689
2023 Q2	$4.88M	Buy	+233,398	New	+$4.77M	0.01%	1073

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Balyasny Asset Management's SLRN Position: Q2 2025 in Review

Balyasny Asset Management sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 1,305,015 shares — an estimated $3.22M sold.

Balyasny Asset Management first reported a position in SLRN in Q2 2023 and held it in 5 quarters. The position peaked at $4.88M in Q2 2023. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

Balyasny Asset Management reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
Balyasny Asset Management sold 1,305,015 ACELYRIN shares in Q2 2025, an estimated $3.22M.
Balyasny Asset Management first reported a position in ACELYRIN in Q2 2023 and held it in 5 quarters.
Balyasny Asset Management's ACELYRIN position peaked at $4.88M in Q2 2023.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Balyasny Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.